跳至主要内容
临床试验/NL-OMON39581
NL-OMON39581已完成不适用

MRI Investigation in Transcatheter Aortic Valve replacement with Claret: a randomized study to assess by MRI the reduction in cerebral embolic lesions during Transcatheter Aortic Valve Replacement with the Claret embolic protection device - MISTRAL-C

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) Patients with severe AS at high operative risk who will undergo planned TAVI
  • 2) Informed consent to participate in the study (i.e. use of Claret device yes or no) and undergo DW -MRI before and after the procedure.
  • 3) Compatible left common carotid artery (>= 5 mm) and brachiocephalic artery (>= 9 mm)
  • diameters without significant stenosis (> 70%) as determined by Multi-Slice Computed
  • Tomography (MSCT) scan

排除标准

  • 1) No written informed consent
  • 2) Standard exclusion criteria for MRI study (see Appendix 4)
  • 3) Anatomical exclusion for filter deployment
  • 4) Permanent Pacemaker/AICD in situ before TAVI
  • 5) Planned implantation of a pacemaker implantation after TAVI.
  • 6) Previous stroke with residual neurological symptoms or dementia
  • 7) Not native Dutch speaking

研究者

相似试验